REDUCTION OF BLOOD PRESSURE VARIABILITY BY AMLODIPINE IN BARORECEPTOR DENERVATED RATS

REFERENCES

• Pessina A. C., Palatini P., Sperti G., Cordone L., Libardoni M., Mos L., Mormino P., Di Marco A., Palu C. D. Evaluation of hypertension and related target organ damage by average day-time blood pressure. Clin Exp Hypertens 1985; A7: 267–278
   Google Scholar
• Parati G., Pomidossi G., Albini F., Malaspina D., Mancia G. Relationship of 24-hour blood presssure mean and variability to severity of target organ damage in hypertension. J Hyperten 1987; 5: 93–98
   PubMed Web of Science ®Google Scholar
• Palatini P., Penzo M., Racioppa A., Zugno E., Guzzardi G., Anaclerio M., Pessina A. C. Clinical relevance of nighttime blood pressure and of daytime blood pressure variability. Arch Int Med 1992; 152: 1855–1860
   PubMed Web of Science ®Google Scholar
• Frattola A., Parati G., Cuspidi C., Albini F., Mancia G. Prognostic value of 24 hour blood pressure variability. J Hypertens 1993; 11: 1133–1137
   PubMed Web of Science ®Google Scholar
• Van Vliet B. N., Hu L. Scott, Chafe L., Montani J. P. Cardiac hypertrophy and telemetered blood pressure 6 weeks after baroreceptor denervation in normotensive rats. Am J Physiol 1996; 271: R1759–R1769
   PubMed Web of Science ®Google Scholar
• Elaut L. La structure de l'artere afferente du glomerule renal chez le chien hypertendu. Comptes Rendus Soc Biol 1934; 115: 1416–1418
   Google Scholar
• Boyd J. D., McCullagh G. P. Experimental hypertension following carotico-aortic denervation in the rabbit. Quart J Exp Physiol 1937–1938; 27: 293–307
   Google Scholar
• Goldman M. L., Schroeder H. A., Dammin G. J. Morphologic alterations in the kidney during prolonged experimental renal and neurogenic hypertension. Am J Path 1952; 28: 528–529
   Web of Science ®Google Scholar
• Dammin G. J., Goldman M. L., Schroeder H. A., Pace G. M. Arterial hypertension in dogs. II. The effects of neurogenic hypertension with a study of periodic renal biopsies over a seven year period. Lab Invest 1956; 5: 72–96
   PubMed Web of Science ®Google Scholar
• Krieger E. M. Neurogenic hypertension in the rat. Circ Res 1964; 30: 511–521
   Google Scholar
• Valet P., Bascands J. L., Pecher C., Cabos G., Moatti J. P., Montastruc J. L., Girolami J. P. Urinary kallikrein excretion following chronic sinoaortic denervation in conscious dogs. Clin Exp Hypertens 1989; A11: 215–231
   Web of Science ®Google Scholar
• Orfila C., Damase-Michel C., Lepert J., Montastruc J., Suc J., Montastruc P., Girolami J. Renal morphological changes after sinoaortic denervation in dogs. Hypertension 1993; 21: 758–766
   PubMed Web of Science ®Google Scholar
• Clement D. L., De Buyzere M., Duprez D. D. Influence of drugs on blood pressure variability. J Hyperten 1994; 12(Suppl 8)S49–S53
   PubMedGoogle Scholar
• Mancia G., Omboni S., Ravogli A., Parati G., Zanchetti A. Ambulatory blood pressure monitoring in the evaluation of antihypertensive treatment: additional information from a large data base. Blood Pressure 1995; 4: 148–156
   PubMedGoogle Scholar
• Fariello R., Boni E., Corda L., Cantalamessa A., Zaninelli A., Pollavini G., Alicandri C., Muiesan G. Extended release felodipine in essential hypertension. Variations in blood pressure during whole-day continuous ambulatory recording. J Hypertens 1991; 4: 27–33
   Web of Science ®Google Scholar
• Zito M., Abate G., Cervone C., Squassante L., Calabrese G. Effects of antihypertensive therapy with lacidipine on ambulatory blood pressure in the elderly. J Hyperten 1991; 9(Suppl 3)S79–S83
   Google Scholar
• Neaton J. D., Grimm R. H., Prineas R. J., Stamler J., Grandits G. A., Elmer P. J., Cutler J. A., Flack J. M., Schoenberger J. A., McDonald R., Lewis C. E., Liebson P. R. Treatment of mild hypertension study: Final results. JAMA 1993; 270: 713–724
   PubMed Web of Science ®Google Scholar
• Leenen F. H.H., Wilson T. W., Bolli P., Larochelle P., Myers M., Handa S. P., Boileau G., Tanner J. Patterns of compliance with once vesus twice daily antihypertensive drug therapy in primary care: A randomized clinical trial using electronic monitoring. Can J Cardiol 1997; 13: 914–920.
   PubMed Web of Science ®Google Scholar
• Packer M., O'Connor C. M., Ghali J. K., Pressler M. L., Carson P. E., Belkin R. N., Miller A. B., Neuberg G. W., Frid D., Wertheimer J. H., Cropp A. B., DeMetts D. L. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med 1996; 335: 1107–1114
   PubMed Web of Science ®Google Scholar
• Donati L., Bühler F. R., Beretta-Piccoli C., Kusch F., Heinen G. Antihypertensive mechanism of amlodipine in essential hypertension: Role of pressor reactivity to norepinephrine and angiotensin II. Clin Pharmacol Ther 1992; 52: 50–59
   PubMed Web of Science ®Google Scholar
• Mattes A., B Lemmer. Effects of amlodipine on circadian rhythms in blood pressure, heart rate, and motility: a telemetric study. Chronobiol Int 1991; 8: 526–538
   PubMed Web of Science ®Google Scholar
• Nayler W. G. The effect of amlodipine on hypertension-induced cardiac hypertrophy and reperfusion-induced calcium overload. J Cardiovasc Pharmacol 1988; 12(Suppl 7)S41–S44
   Google Scholar
• Kanno Y., Suzuki H., Okada H., Saruta T. Renal protective effects of amlodipine on partially nephrectomized spontaneously hypertensive rats fed a high salt diet. J Cardiovasc Pharmacol 1994; 23: 480–484
   PubMed Web of Science ®Google Scholar
• Morel N., Godfraind T. Selective interaction of the calcium antagonist amlodipine with calcium channels in arteries of spontaneously hypertensive rats. J Cardiovasc Pharmacol 1994; 24: 524–533
   PubMed Web of Science ®Google Scholar
• Nayler W. G. End organ involvement and calcium antagonist therapy: animal studies. J Cardiovasc Pharmacol 1994; 24(Suppl A)S12–S17
   PubMedGoogle Scholar
• Saruta T., Kanno Y., Hayashi K., Suzuki H. Renal effects of amlodipine. J Human Hypertens 1995; 9(Suppl I)S11–S16
   PubMedGoogle Scholar
• Santajuliana D., Hornfeldt B. J., Osborn J. W. Use of ganglionic blockers to assess neurogenic pressor activity in conscious rats. J Pharm Toxicol Methods 1996; 35: 45–54
   PubMed Web of Science ®Google Scholar
• Stopher D. A., Beresford A. P., Macrae P. V., Humphrey M. J. The metabolism and pharmacokinetics of amlodipine in humans and animals. J Cardiovasc Pharmacol 1988; 12(Suppl 7)S55–S59
   PubMed Web of Science ®Google Scholar
• Yamada S., Sugimoto N., Uchida S., Deguchi Y., Kimura R. Pharmacokinetics of amlodipine and its occupancy of calcium antagonist receptors. J Cardiovasc Pharmacol 1994; 23: 466–472
   PubMed Web of Science ®Google Scholar
• Floras J. S., Hassan H. O., Jones J. V., Osikowska B. A., Silver P. S., Sleight P. Factors influencing blood pressure and heart rate variability in hypertensive humans. Hypertens 1988; 11: 273–281
   PubMed Web of Science ®Google Scholar
• Floras J. S., Hassan H. O., Jones J. V., Osikowska B. A., Silver P. S., Sleight P. Consequences of impaired arterial baroreflexes in essential hypertension: effects on pressor responses, plasma noradrenaline and blood pressure variability. J Hyperten 1988; 6: 525–535
   PubMed Web of Science ®Google Scholar
• Garcha R., Schachter M., Hughes A., Thom S. M., Sever P. Amlodipine inhibition of alpha-agonist induced contraction in human resistance vessels. J Hypertens 1991; 9(suppl 6)S368–369
   Google Scholar
• Alper R. H., Jacob H. J., Brody M. J. Regulation of arterial pressure lability with chronic sino-aortic deafferentation. AM J Physiol 1987; 253: H466–H474
   PubMed Web of Science ®Google Scholar